Medication: reimbursemen of specific anti-migraine drugs worldwide 2011

This statistic displays the reimbursement of specific migraine medications worldwide as of 2011. In 40 percent of responding countries, the expenses for anti-migraine drug Ergotamine were reimbursed, while in 23 percent of countries the reimbursement was in part.

Reimbursement of anti-migraine medication worldwide as of 2011, by drug type*

Loading statistic...
You need to log in to download this statistic
Register for free
Already a member?
Log in
Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

2011

Region

Worldwide, Asia, Europe

Survey time period

as of 2011

Age group

Supplementary notes

* The source states that information was collected in a questionnaire survey of neurologists, general practitioners and patients’ representatives from 101 countries, performed from October 2006 until March 2009. Epidemiological data were compiled from published studies through a systematic review, and supplemented by data gathered in population-based studies undertaken within the Global Campaign.

Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Single Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.

Statistics on "Headache and migraine in the U.S."

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.